Cystic Fibrosis Trust

We're the only UK-wide charity uniting people to stop cystic fibrosis

Cystic Fibrosis Trust
We're the only UK-wide charity uniting people to stop cystic fibrosis

Cystic Fibrosis Trust supports research into all aspects of cystic fibrosis (CF) across the full research pathway from basic academic science, translational research to clinical studies to bring impact to people with cystic fibrosis.

The Trust supports basic and clinical research through our Strategic Research Centre and Development Award schemes; supports academic and industry-initiated research through our leverage funding Venture and Innovation Award scheme and will support translational science through our Translational Innovation Hub Network. The CF Antimicrobial Resistance (AMR) Syndicate is a partnership between Cystic Fibrosis Trust, Medicines Discovery Catapult and LifeArc.

It brings together leading experts in CF and AMR from industry, academia and the clinic with people living with CF to accelerate the development and translation of new CF antimicrobials and diagnostics, bringing new medicines to people who need them. To enable and accelerate translation, the Trust manages the UK Clinical Trial Accelerator Programme and the UK CF Registry. Our involvement team can coordinate PPIE activity with those living with CF throughout the research pipeline.

Register Your Interest

Name(Required)